Cambridge scientists have created a breakthrough material that can sense tiny chemical changes in the body, such as the ...
The FDA has approved updated labeling for Vyjuvek (beremagene geperpavec-svdt), a topical gene therapy for dystrophic epidermolysis bullosa.
A Cambridge University study introduces a "smart" gel that detects pH changes from inflammation or tumors. This material ...
Learn how softgels have helped sponsors across the industry improve the efficacy and stability of their therapeutics.
The $10 million initiative will enhance IBD treatment by developing an AI tool for personalized dietary strategies, improving ...